at www.tipranks.com (Tue, 3-Nov 1:00 AM)
Krystal Therapeutics’ Strong Vyjuvek Growth Supports Buy Rating Despite Price Target Cut to $390
at www.tipranks.com (Mon, 2-Nov 9:38 PM)
Krystal Biotech falls as data for pipeline programs pushed to 2027
at seekingalpha.com (Mon, 2-Nov 10:52 AM)
Krystal Biotech GAAP EPS of $2.05 beats by $0.28, revenue of $1.1B beats by $973.46M
at seekingalpha.com (Mon, 2-Nov 7:12 AM)
Here are the major earnings before the open Monday
at seekingalpha.com (Sun, 1-Nov 5:00 PM)
